AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 103 filers reported holding AKERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 4.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $150,678 | +31.5% | 2,979 | +21.4% | 0.01% | +33.3% |
Q2 2023 | $114,577 | +51.2% | 2,454 | +23.9% | 0.01% | +50.0% |
Q1 2023 | $75,793 | -35.8% | 1,981 | -8.1% | 0.00% | -20.0% |
Q4 2022 | $118,149 | +95.4% | 2,156 | +21.4% | 0.01% | +66.7% |
Q3 2022 | $60,473 | +260.3% | 1,776 | 0.0% | 0.00% | +200.0% |
Q2 2022 | $16,783 | -33.4% | 1,776 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $25,201 | -84.2% | 1,776 | -76.4% | 0.00% | -50.0% |
Q4 2021 | $159,175 | -5.4% | 7,526 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $168,206 | -9.9% | 7,526 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $186,720 | +66.7% | 7,526 | +95.0% | 0.00% | +50.0% |
Q1 2021 | $111,979 | +12.4% | 3,860 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $99,588 | -16.2% | 3,860 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $118,849 | +23.6% | 3,860 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $96,191 | – | 3,860 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |